Aims and background: Treatment of local-regional recurrent rectal carcinoma is a challenging problem, and local control may be dose dependent; doses should probably exceed 60 Gy. Our aim was to verify the possibility to deliver 66 Gy to the target, but less than 35 Gy to the small bowel, comparing different 30 irradiation techniques, in a selected group of patients. Methods: Five patients with local recurrent rectal carcinoma were selected as representative of different presentations of the disease. Gross tumor volume and clinical target volume were defined [by RS]. Tumors ranged between 182 and 540 cc, and small bowel volumes between 748 and 1050 cc. A threefield technique, coplanar multiple fields, noncoplanar fields and a proton beam were compared using dose volume histograms. A positive result was scored when <?:90% of the tar-get received the prescribed dose with no more than 5% of the small bowel receiving more than 35 Gy. Doses were escalated in steps of 2 Gy from 60 to 66 Gy. Results: The number of plans fitting the constraints were 7/19, 11/19, 18/19 for doses of 66 Gy, 64 Gy and 62 Gy, respectively. The stage of the tumor did not seem to correlate with the possibility to homogeneously cover the target with the prescribed dose. Conclusions: Simple coplanar and complex coplanar techniques (up to six fields), positioning the patient in a prone position with dislocation of the bowel, seem to be the best solutions to treat almost all of the patients with doses of 64 Gy. Where higher doses are concerned, it is not possible to suggest a "standard" solution. More personalized techniques have to be tested to define the best option.
Introduction
Treatment of local-regional recurrence (LR), following a low anterior or perineal resection for rectal carcinoma, may be a challenging clinical problem. The frequency of LR ranges, after surgery only, from 10% to over 30% 1 • 2 , depending on the site and stage of the tumor, type of surgery and experience of the surgeon. Radiation delivered before or after surgery has considerably reduced the incidence of LR 3 • 18 • It is widely employed and under further evaluation to better establish its role with or without concomitant chemotherapy and new drugs. In the current setting of total mesorectal excision and preoperative treatment, the frequency of LR has been considerably reduced. However, new problems have to be faced in the treatment of patients who have undergone preoperative treatment.
There is no established treatment modality of the LR to be applied to the different presentations and extensions of pelvic disease. Surgery 2 may be curative when the LR is limited to the anastomosis 19 -25 providing the best local control results reported in the literature. When the disease is bulky or not respectable, 5-year survival rates are poor 26 -31 and seldom reported even with the most aggressive treatment protocols 27 • Combined programs are based on radiation therapy with external beam (EB) treatments and intraoperative irradiation (IORT) 26 -31 • Tumoricidal doses may be above 60 Gy, but it may be difficult to deliver, with EB irradiation only, such a dose to the target volume without increasing the risk of small bowel toxicity. To evaluate the possibility to develop a dose-escalating protocol to deliver higher doses to LR rectal carcinomas, it may be mandatory to test personalized treatment techniques in the individual patient and use precise constraints for the normal structures. For these reasons, this report analyses the results obtained in a group of 5 selected patients with LR rectal carcinoma, comparing four different techniques of irradiation aimed at delivering 66 Gy to the target, but less than 35 Gy to the small bowel.
Patients and methods
Patients affected by LR rectal carcinoma and referred to the Radiation Therapy Department of the University of Florence undergo EB radiation therapy and concomitant chemotherapy (5-fluorouracil, 225 mg/m 2 /day continuous infusion) before surgical resection of the pelvic tumor in selected cases. The irradiation is usually performed with a coplanar field technique (three or more fields), delivering to the gross tumor volume, plus approximately 2 cm of surrounding tissues (clinical target volume), the dose of 54 Gy in 6 weeks.
Among the patients referred between January 1998 and December 2002, 5, with different local extension of the pelvic disease classified according to Suzuki's method 32 , were selected for the present evaluation, and their main features are reported in Table 1 . Computerized tomography (CT) scans were re-evaluated, and gross tumor volumes and clinical target volumes were delineated by one of the authors (RS). The small bowel, the bony structures, the bladder and the normal large bowel were delineated as well. An average of 45 images per CT scan were available for each patient; scans were obtained, with the patients in the prone position and no immobilization device, from a plan through the interspace between the third and fourth lumbar vertebra to the perineum. The CT scan interval was 5 mm in all of the patients. On the basis of these data, four different treatment techniques were developed for patients 1, 2, 3 and 5, but only three for patient 4; dose-volume histograms were calculated for the tumor and normal structures. We compared a "conventional" three-field technique (one posterior and two lateral fields), a coplanar multiple field (up to six coplanar fields), a noncoplanar technique, and a proton beam (one direct posterior field only). All of the techniques were developed and compared using the ISIS 3D treatment planning system, which is able to perform conformal treatment with photon and proton beams. All of the photon beams (6-25 MV) in use in our department, as well as the 200 Me V proton beam of the Protontherapy Center in Orsay (France), are available in the system. The proton beam has a water penetration of about 25 cm and a 10-cm field diameter. Aluminum range modulators and combinations of range shifters of different materials achieve uniform dose distribution at an adequate depth 33 . Doses were prescribed to the International Commission Radiation Units (ICRU) point; prescribed doses were escalated from 60 to 66 Gy in steps of 2 Gy; the maximum, minimum and average doses were obtained. We scored as a positive result the fact that over 90% of the target volumes would receive the prescribed dose (60, 62, 64 and 66 Gy, respectively) with no more than 5% of the volume of the small bowel receiving more than 35 Gy.
Results
Tables 2-6 report the results obtained in terms of maximum, minimum and average doses (Gy) delivered to the target and small bowel when prescribing 66 Gy to the ICRU point. In the same Tables, the percentage of the tumor receiving the prescribed dose (66 Gy) and the amount of intestine receiving a dose greater than 35 Gy are reported. Figure I summarizes the results in terms of percentage of the target receiving at least 90% of the prescribed dose for doses ranging between 60 and 66 Gy. Figure 2 represents, for all of the 5 studied patients, the sagittal reconstruction of the body contours, the target volume (in red), the intestine (in green) and their relationships. Target volumes ranged between I 82 and 540 cc and small bowel volumes between 748 and 1050 cc.
When the prescribed dose is 60 Gy, all of the patients can receive a treatment to homogeneously irradiate the tumor independently of the technique of irradiation ( Figure IA) . When the dose is escalated by 2 Gy steps, coverage of the target with the prescribed dose is more difficult, and 66 Gy can be delivered to ~90% of the tumor volume with at least one of the developed techniques in only 3 patients ( Figure ID ). The number of plans judged to fit the established constraints were 11119 and I 8119 for doses of 64 Gy and 62 Gy, respectively. When the prescribed dose was 66 Gy, only 7 of the I 9 developed plans were adequate to cover over 90% of the target with this dose.
Tumor volume was not the main factor conditioning the homogeneous coverage of the target. In spite of the fact that patient I presented the largest tumor, all of the irradiation techniques covered the target adequately, with at least 94% of the volume of the LR receiving 66 Gy.
Stage, according to Suzuki's classification, does not seem to correlate with the possibility to cover the target with the prescribed dose. As is shown by Figure 2 , the cranial extension of the target and the relationship between tumor and intestine condition the result.
As regards the small bowel, the percentages of the volume receiving the maximum, minimum and average doses are also reported in Tables 2 to 6. A considerable amount of the intestine (30%) would receive a higher dose than the prescribed constraint for this organ (35 Gy) in only one patient (patient 4, stage Fl) due to the almost complete encroachment of the tumor upon the bowel (Figure 2 ). In all of the evaluated patients, limited amounts of the intestine would receive more than 35 Gy on the boundaries between tumor and bowel volumes. an EB. The doses we have simulated to deliver are higher than those usually delivered with EB only (54 Gy), but might be similar to those delivered with EB and IORT. Unless this cannot be surely stated, the simple arithmetic sum of doses delivered with different modalities (EB+ IORT) is difficult to compare, in terms of biological effect, with the efficacy of one modality only. However, IORT is feasible only after EB irradiation and down-sizing of the tumor. If high doses of irradiation are delivered to large pelvic tumor volumes, sparing the small bowel, it may contribute to better local control rates without preventing IORT. After EB irradiation, 50% and 75% of locally advanced primary rectal cancers become amenable for complete surgical resection 34 -40 , and as much as 75% to 89% are resectable 41 -43 . Although resection can be achieved in most of the patients after EB irradiation, the 5-year incidence of LR still remains in the range of 30-55%, with survival rates of 10-26% 34 -36 .4 4 -47 . Local control is dose-dependent, and the dose should exceed 60 Gy 48 -49 . However, as small bowel toxicity may prevent delivery of such high doses, 50 Gy is considered optimal in most patients 50 -52 . LR may be more resistant than an advanced primary tumor due to intrinsic factors (oxygen distribution, proportion of aneuploid and diploid cells, proliferating pool, etc.) or extrinsic conditions such as anatomic distortion following surgery. It may need higher doses to achieve down-sizing of the disease and a better local control. Our experience was based on a few selected cases, with different local extensions of the disease (Suzuki's stage FO-F2), and aimed at showing that a standard technique cannot always be applied in all patients when a dose escalation is planned. Only a few very preliminary conclusions may be drawn by this experience.
1. The volume of the tumor and stage do not always condition the feasibility of the treatment, even though they may be related. As regards doses of 64 Gy, almost all of the patients ( 4/5) would have received this dose with at least one of the tested techniques. Coplanar multiple conformal fields (3 to 4 fields) represent the appropriate option in most cases.
2. The dose of 64 Gy is higher (18%) than that conventionally delivered (50-54 Gy), but its value in the local control of the disease has not yet been completely assessed.
3. A dose of 35 Gy is a low constraint for the small bowel, and doses as high as 45 Gy may be delivered to partial volumes of the bowel without high-grade morbidi-ty53; very small portions of the intestine (patients 1, 2 and 5) would receive, in this experience, high doses where the tumor encroaches upon the intestine; as these portions of the bowel may be fixed or have a lesser degree of free- dom, the risk of late damage may be increased, thereby justifying strict constraints for the small intestine. 4. Keeping the constraint for the bowel as low as pos-sible requires the development of personalized and time-consuming techniques, but is expected to reduce the risk of late side effects.
5.
Simple coplanar field combinations (three fields, patient in a prone position, dislocation of the bowel with a belly board) and complex coplanar techniques (six fields, same positioning as above) seem to be the best solutions to treat almost all of the patients with doses in the range of 64 Gy. Where higher doses are concerned, it is not possible to suggest a "standard" solution, and more personalized techniques have to be tested to define the best option.
6. Despite the ballistic advantages of a proton beam, a single posterior proton beam is not as adequate as a coplanar technique employing up to six fields. Air in
